Xenetic BiosciencesXBIO
13F holders, Q1 2024 (March 31)7holders
$3.76avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Xenetic Biosciences Inc. (XBIO) in their 13F filings. The largest holders were Geode Capital Management, LLC ($41K), UBS Group AG ($12K) and JTC Employer Solutions Trustee Ltd ($10K).
- Company
- Xenetic Biosciences Inc.
- CUSIP
- 984015602
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 7 holders
| Geode Capital Management, LLC | 0.00% | No change | 10,998 | $41K |
| UBS Group AG | 0.00% | Add +908.2% | 3,075 | $12K |
| JTC Employer Solutions Trustee Ltd | 0.00% | No change | 2,700 | $10K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,900 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.3% | 925 | $3K |
| Wells Fargo & Company | 0.00% | No change | 11 | $41 |
| Morgan Stanley | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is XBIO's weight in each manager's 13F, not the share of Xenetic Biosciences Inc. the manager owns.